Just to clarify for others reading: Statens Serum Institut (SSI) is a government agency, founded and primarily funded by the Danish Ministry of Health. It’s not a private company profiting from vaccines. In fact, SSI sold its vaccine production business in 2016 to AJ Vaccines and now focuses on public health, disease surveillance, and research.
The claim that their “salaries come from vaccine profits” is simply false. While they conduct vaccine-related research and some of their funding comes from competitive grants, their core operations are state-funded. Saying "Primary funding source: None" in a paper means no external funding for that specific study, not that the authors are secretly paid by pharma.
It’s important to hold science accountable — but misrepresenting basic facts about an institution’s funding just spreads confusion, not clarity.
FORGET ABOUT IT. You'd have to send traditional letters back and forth between your local tax office and the tax office of the dividend origin country. Usually the foreign tax office demands their form be rubber stamped by your local tax office. Obviously your local tax office will not rubber stamp a form by foreign tax office in a foreign language, but they don't care.
Tricky, maybe, because it was bought in a Roth IRA - which is not taxed. And therefore, I think, not eligible for tax refunds. I probably should have bought it in a normal trading account.
The claim that their “salaries come from vaccine profits” is simply false. While they conduct vaccine-related research and some of their funding comes from competitive grants, their core operations are state-funded. Saying "Primary funding source: None" in a paper means no external funding for that specific study, not that the authors are secretly paid by pharma.
It’s important to hold science accountable — but misrepresenting basic facts about an institution’s funding just spreads confusion, not clarity.